Sample Request

Global Cell Therapy Market Size, By Therapeutic area(Malignancies, Musculoskeletal disorders, Autoimmune disorders, Dermatology), By Cell Type(Stem cell therapies, Non-stem cell therapies) Forecasts 2017 - 2028

SELECT LICENSE:

Published on 10/26/2021| Code: CMM460001| Category: Healthcare & Life Sciences| Total Pages: 101

The global cell therapy market size was valued at USD 5.77 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 14.5% from 2021 to 2028.

The global cell therapy market was valued at less than US$ 5.77 Billion in 2020 and is expected to surpass US$ 51.82 Billion by 2028. The market is mainly driven by the large number of clinical studies of cell based therapies which can be attributed to the presence of government and private funding agencies that are constantly offering grants to support projects across various stages of clinical trials. Furthermore, the need of better and targeted therapies in the management of diseases such as cancer and cardiovascular diseases has also resulted in overall increase in research and development activities, thus boosting the growth of market.

Currently, cell therapy is one of the most exciting fields in translational medicine as it can effectively alleviate the underlying cause of genetic and acquired disease. The cell therapy works by restoring or altering cells and it functions by cultivating or manipulating cells outside the body before they are again injected into patient's body. The cell therapies consist of all aspects of cellular immunotherapies, cellular medications, and other therapies which include cells from donor and recipients for cell therapies. Continuous research and development in cell therapy has accelerated at a fast rate, with the increasing number of products entering clinical trials and development.

Global Cell Therapy Market: By Therapeutic area
Malignancies
Musculoskeletal disorders
Autoimmune disorders
Dermatology
Others

Global Cell Therapy Market: By Cell Type
Stem cell therapies
Non-stem cell therapies

Global Cell Therapy Market: Key Players
Gilead Science Inc. (Kite Pharma Inc.)
Spark Therapeutics
Novartis
Organogenesis
Amgen
Osiris
Dendreon
Vericel
Medipost
Pharmicell Co Ltd.
Bristol Meyer Squibb
Mesoblast
Stemmedica
Adaptimmune

Global Cell Therapy Market: Regions
• North America (United States, Canada and Mexico)
• Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
• Asia Pacific (China, Japan, India, Southeast Asia and Australia)
• Latin America (Brazil, Argentina and Colombia)
• Middle East and Africa

Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
2.1 Market Snapshot

Chapter 3 Cell Therapy Market Variables, Trends, and Scope
3.1 Market Trends and Outlook
3.2 Market Segmentation and Scope
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Rise in number of clinical studies for cellular therapies
3.3.1.2 Growing adoption of regenerative medicine
3.3.1.3 Introduction of novel platforms and technologies
3.3.2 Market restraint analysis
3.3.2.1 Ethical concerns
3.3.2.2 Clinical issues pertaining to development & implementation of cell therapy

5.2.2 Cell therapy market for clinical use, by therapeutic area
5.2.2.1 Malignancies
5.2.2.1.1 Global cell therapy market for malignancies, 2017 - 2028 (USD Million)
5.2.2.2 Musculoskeletal disorders
5.2.2.3 Autoimmune disorders
55.2.2.4 Dermatology
5.2.2.5 Others
5.2.2.5.1 Global cell therapy market for other therapeutic areas, 2017 - 2028 (USD Million)
5.2.3 Cell therapy market for clinical use, by cell type
5.2.3.1 Stem cell therapies
5.2.3.1.1 Global stem cell therapies market, 2017 - 2028 (USD Million)
5.2.3.1.2 Bone marrow, blood, & umbilical cord-derived stem cell therapies
5.2.3.1.2.1 Global bone marrow, blood, & umbilical cord-derived stem cell therapies market, 2017 - 2028 (USD Million)
5.2.3.1.3 Adipose-derived stem cell therapies
5.2.3.1.4 Other stem cell therapies
5.2.3.2 Non-stem cell therapies
5.2.3.2.1 Global non-stem cell therapies market, 2017 - 2028 (USD Million)
5.3 Research Use
5.3.1 Global cell therapy market for research use, 2017 - 2028 (USD Million)
5.2.2 Cell therapy market for clinical use, by therapeutic area

Chapter 6 Cell Therapy Market Categorization: Therapy Type Estimates & Trend Analysis
6.1 Cell Therapy Market: Therapy Type Movement Analysis
6.2 Allogenic Therapies
6.2.1 Global cell therapy market for allogenic therapies, 2017 - 2028 (USD Million)
6.3 Autologous Therapies
6.3.1 Global cell therapy market for autologous therapies, 2017 - 2028 (USD Million)

Chapter 7 Cell Therapy Market Categorization: Regional Estimates & Trend Analysis, by Use-type & Therapy Type
7.1 Cell Therapy Market Share by Regional, 2020 & 2028
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 U.K.
7.2.3. France
7.2.4.Italy
7.2.5. Spain
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3. India
7.4.4. Australia
7.5 Latin America
7.5.1 Brazil
7.5.2. Mexico
7.6 Middle East and Africa (MEA) 7.6.1 South Africa
7.6.1. Israel
7.6.2. Turkey
7.6.3. Iran
7.6.4. Saudi Arabia
7.6.5. South Africa
7.6.3. Iran
7.6.4. Saudi Arabia

Chapter 8. Competitive Landscape
8.1. Gilead Science Inc. (Kite Pharma Inc.)
8.2. Spark Therapeutics
8.8 Novartis
8.4. Organogenesis
8.5. Amgen
8.6. Osiris
8.7. Dendreon
8.8. Vericel
8.9. Medipost
8.10. Pharmicell Co Ltd.
8.11. Bristol Meyer Squibb
8.12. Mesoblast
8.13. Stemmedica
8.14. Adaptimmune

Our Clients

BIC
Suntory Holdings
Continental AG
Ernst Klett
felix
IF Logo
ITC logo
jc
KB
KKR
LR
LSC
Prospect
SRG
Sumitomo
Taichin logo
The Cleanest Way
Meat & Livestock Australia Limited
LEK
IFFCO
STTS
Laundry Capital LLC
Chippenhook Corporation
SAB
IJIN
Hooton
Medica
Medalliacne
Shanghai Chenzhu Instrument Co., Ltd.
Sanofi
Kleen Linnebo und Partner GbR
Bond-Pro, Inc.
E&L Faster Food Imports Inc.
Okinawa Institute of Science and Technology
Mizuno Corp
AutoX

Need Help?

Please fill form below:

Contact Us

99 WALL STREET #2124 NEW YORK, NY 10005